TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy

阅读量：

作者：

SM Bemiller，TJ Mccray，K Allan，SV Formica，G Xu，G Wilson，ON Kokiko-Cochran，SD Crish，CA Lasagna-Reeves，RM Ransohoff

展开

摘要：

Genetic variants of theTriggeringReceptorExpressed onMyeloid Cells-2(TREM2) confer increased risk of developing late-onset Alzheimer's Disease (LOAD) and other neurodegenerative disorders. Recent studies provided insight into the multifaceted roles of TREM2 in regulating extracellular β-amyloid (Aβ) pathology, myeloid cell accumulation, and inflammation observed in AD, yet little is known regarding the role of TREM2 in regulating intracellular microtubule associated protein tau (MAPT; tau) pathology in neurodegenerative diseases and in AD, in particular. Here we report that TREM2 deficiency leads to accelerated and exacerbated hyperphosphorylation and aggregation of tau in a humanized mouse model of tauopathy. TREM2 deficiency also results, indirectly, in dramatic widespread dysregulation of neuronal stress kinase pathways. Our results suggest that deficiency of microglial TREM2 leads to heightened tau pathology coupled with widespread increases in activated neuronal stress kinases. These findings offer new insight into the complex, multiple roles of TREM2 in regulating Aβ and tau pathologies. The online version of this article (10.1186/s13024-017-0216-6) contains supplementary material, which is available to authorized users.

展开

关键词：

TREM2 Tauopathy Alzheimers disease Inflammation Immunity

DOI：

10.1186/s13024-017-0216-6

被引量：

年份：

2017